VJHemOnc is committed to improving our service to you

iwCLL 2019 | Predicting suboptimal response through intermediate MRD

VJHemOnc is committed to improving our service to you

Andrew Rawstron

Andrew Rawstron, PhD, Leeds Teaching Hospitals NHS Trust, Leeds, UK, speaking at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK. Dr Rawston speaks on the predicting suboptimal response through intermediate measurable residual disease (MRD).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter